rispolept consta 50 mg depotinjektionsvæske, pulver og solvens til suspension
europharma.dk aps - risperidon - depotinjektionsvæske, pulver og solvens til suspension - 50 mg
buprenorphin/naloxon "g.l. pharma" 4+1 mg resoribletter, sublinguale
g.l. pharma gmbh - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 4+1 mg
libroxar 2+0,5 mg resoribletter, sublinguale
laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg
vectibix
amgen europe b.v. - panitumumab - kolorektale neoplasmer - antineoplastiske midler - vectibix is indicated for the treatment of adult patients with wild-type ras metastatic colorectal cancer (mcrc): , in first-line in combination with folfox or folfiri. i anden linje i kombination med folfiri for patienter, der har modtaget første linje fluoropyrimidine-baseret kemoterapi (undtagen irinotecan). som monoterapi efter svigt af fluoropyrimidine-, oxaliplatin eller irinotecan-holdig kemoterapi regimer.
propolipid 10 mg/ml injektions-/infusionsvæske, emulsion, fyldt injektionssprøjte
fresenius kabi ab - propofol - injektions-/infusionsvæske, emulsion, fyldt injektionssprøjte - 10 mg/ml
jurnista 16 mg depottabletter
janssen-cilag a/s - hydromorphonhydrochlorid - depottabletter - 16 mg
jurnista 32 mg depottabletter
janssen-cilag a/s - hydromorphonhydrochlorid - depottabletter - 32 mg
jurnista 64 mg depottabletter
janssen-cilag a/s - hydromorphonhydrochlorid - depottabletter - 64 mg
jurnista 8 mg depottabletter
janssen-cilag a/s - hydromorphonhydrochlorid - depottabletter - 8 mg
subutex 100 mg depotinjektionsvæske, opløsning
indivior europe limited - buprenorphin - depotinjektionsvæske, opløsning - 100 mg